Company news

Opus Genetics, Inc. news in 2022

Opus Genetics, Inc.'s news releases, calls and decks from 2022, newest first.

View company

Ocuphire Provides Corporate Update: Announcing Enrollment Completion of Phase 3 Nyxol Trial, Enrollment Initiation of Nyxol Pediatric Trial, and an Investor R&D Day in January

January 4, 2022

Decks in 2022